be_ixf;ym_202206 d_30; ct_50

Select Page

Nick Tate

Nick TateNick Tate Editorial Director for Banyan Hill Publishing

Nick Tate is the editorial director for Banyan Hill Publishing. Prior to being named to his current position, Nick was the senior editorial manager for Bold Profits Daily, Profits Unlimited and Paul Mampilly’s nine other premium tradition publications.

As a best-selling author, seasoned journalist and TV commentator specializing in finance and biotech, Nick is all about big ideas and innovations — always keeping his followers informed on the next big thing.

His work has appeared in The Miami Herald, The Atlanta Journal-Constitution, South Florida Business Journal, Newsmax Magazine, South Florida Sun Sentinel, Boston Herald, and on Newsmax TV and the Al Jazeera network.

His top-selling book, the ObamaCare Survival Guide, was on the Publishers Weekly and The New York Times best-sellers lists for 22 weeks — reaching No. 1 on The Times list for paperback advice books.

Tate also co-authored Baby Boomer Survival Guide: Live, Prosper, and Thrive in Your Retirement. And he published two other books — the Encyclopedia of Natural Healing and The Sick Building Syndrome — following a year-long journalism fellowship at the Harvard School of Public Health.

Tate’s three-decades-long commitment to keeping the public well-informed is why Banyan Hill Publishing recruited him in 2018 to join Paul Mampilly’s team.

Nick Tate's Articles

Tesla & teladoc hold stocks Tesla & Teladoc: 2 Stocks Show You Why to Hold
January 27, 2022 Bold Profits Daily, Investing, Stocks
- Here’s why to stay bullish through volatility and hold your America 2.0 stocks.
future of food meat alternatives Why Invest in the “Future of Food”? - To get real, lasting growth, you need innovation. Take something from the old world and make it more efficient, easier, sustainable in the new world.
telehealth investment 2022 Telehealth-Trend: Invest for 63-Fold Growth - Here’s a sign that telemedicine is here to stay — and a great investment to make now.
Beyond Turkey? - This Thanksgiving is showcasing the growing meatless market — the future-of-food trend. Here’s the driving force (and one buy) for it.
biotech stocks to buy 3 Biotech Innovations Driving America 2.0 Stocks Up - The genetics-biotech revolution is remaking our $16 trillion health care industry. Here’s how to upgrade your portfolio for America 2.0 medicine.
3d printing vaccines 3D-Printed Vaccine: New Catalyst for Stocks - A new 3D-printing advance will change how billions of vaccines are delivered each year — that’s billions with a “B”! — showcasing a massive opportunity for you.
3d printing and precision medicine Why Invest in 3D Printing? Life-Changing Reasons (X2) - This will go down in the medical history books for sure, but it also showcases an opportunity for America 2.0 investors like you.
3D Printing and Precision Medicine 3D Printing + Precision Medicine = Profits! - This is a brand-new 3D printing and precision medicine breakthrough! Give yourself as many chances as you can to win.
2020 olympic winner 3d printing Olympic Gold-Medal Winner: 3D Printing! - This year’s Olympics didn’t just showcase the world’s most elite athletes … it set 3D printing up front and center. And here’s your way in before the 5X rise!
mrna precision medicine No. 1 Stock for Holy Grail of Medicine - It’s the Holy Grail of medicine: An America 2.0 biotech company working on a once-in-a-lifetime flu vaccine. Get the game-changing stock now.

Newsletter Sign Up

Sponsored

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I bought my first Of Paul’s stocks Nov. 1, 2017. I’m happy to say that I’m ahead $14,000. That’s more then 1/3 of what I invested with my money, and in 9 months. Thank you, Paul, you’re the real deal.”

- Larry

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

“Loving this. Should have started a long time ago.”

- Jay